135 related articles for article (PubMed ID: 10365092)
1. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours.
Saegusa M; Hashimura M; Machida D; Okayasu I
J Pathol; 1999 Jan; 187(2):173-83. PubMed ID: 10365092
[TBL] [Abstract][Full Text] [Related]
2. CD44 expression in cervical intraepithelial neoplasia (CIN) and carcinoma.
Gorham H; Woodman A; Goodison S; Marsh J; Charnock M; Manek S; Sugino T; Tarin D
Mol Diagn; 1999 Mar; 4(1):45-56. PubMed ID: 10229774
[TBL] [Abstract][Full Text] [Related]
3. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
[TBL] [Abstract][Full Text] [Related]
4. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer.
Shimabukuro K; Toyama-Sorimachi N; Ozaki Y; Goi T; Furukawa K; Miyasaka M; Aso T
Gynecol Oncol; 1997 Jan; 64(1):26-34. PubMed ID: 8995543
[TBL] [Abstract][Full Text] [Related]
5. CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer.
Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T
Eur J Cancer; 1998 Dec; 34(13):2107-11. PubMed ID: 10070319
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
Akasofu M; Oda Y
Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
[TBL] [Abstract][Full Text] [Related]
7. nm23-H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Lee CS; Gad J
Pathol Int; 1998 Oct; 48(10):806-11. PubMed ID: 9788265
[TBL] [Abstract][Full Text] [Related]
8. CD44 expression in benign, premalignant, and malignant ovarian neoplasms: relation to tumour development and progression.
Saegusa M; Machida D; Hashimura M; Okayasu I
J Pathol; 1999 Nov; 189(3):326-37. PubMed ID: 10547593
[TBL] [Abstract][Full Text] [Related]
9. Expression of phosphorylated histone H2AX (γ-H2AX) in normal and neoplastic squamous epithelia of the uterine cervix: an immunohistochemical study with epidermal growth factor receptor.
Brustmann H; Hinterholzer S; Brunner A
Int J Gynecol Pathol; 2011 Jan; 30(1):76-83. PubMed ID: 21131828
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study.
Faleiro-Rodrigues C; Lopes C
Pathobiology; 2004; 71(6):329-36. PubMed ID: 15627844
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
[TBL] [Abstract][Full Text] [Related]
12. CD44 is a marker of endocervical neoplasia.
Ibrahim EM; Blackett AD; Tidy JA; Wells M
Int J Gynecol Pathol; 1999 Apr; 18(2):101-8. PubMed ID: 10202665
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of Wnt-11 and squamous cell carcinoma antigen expression in cervical cancer.
Wei H; Wang N; Zhang Y; Wang S; Pang X; Zhang J; Luo Q; Su Y; Zhang S
Med Oncol; 2014 May; 31(5):933. PubMed ID: 24737009
[TBL] [Abstract][Full Text] [Related]
14. Expression of bcl-2 and bax in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Aletra C; Ravazoula P; Scopa C; Kounelis S; Sotiropoulou G; Kourounis G; Ladopoulos I; Bonikos D
Eur J Gynaecol Oncol; 2000; 21(5):494-8. PubMed ID: 11198041
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix.
Bonds L; Baker P; Gup C; Shroyer KR
Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751
[TBL] [Abstract][Full Text] [Related]
16. Differentially expressed proteins among normal cervix, cervical intraepithelial neoplasia and cervical squamous cell carcinoma.
Zhao Q; He Y; Wang XL; Zhang YX; Wu YM
Clin Transl Oncol; 2015 Aug; 17(8):620-31. PubMed ID: 25893434
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of BRG-1 repressed expression of CD44s in cervical neuroendocrine carcinoma and adenocarcinoma.
Kuo KT; Liang CW; Hsiao CH; Lin CH; Chen CA; Sheu BC; Lin MC
Mod Pathol; 2006 Dec; 19(12):1570-7. PubMed ID: 16998464
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of differentially expressed proteins in normal cervix, cervical intraepithelial neoplasia and cervical squamous carcinoma tissues].
Zhao Q; Wu YM; He Y; Wang XL; Chen S; Qian XH; Zhang YX
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):914-20. PubMed ID: 24506961
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma.
Gotoda T; Matsumura Y; Kondo H; Ono H; Kanamoto A; Kato H; Watanabe H; Tachimori Y; Nakanishi Y; Kakizoe T
Gut; 2000 Jan; 46(1):14-9. PubMed ID: 10601048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]